Translational deep learning models for risk stratification to predict prognosis and immunotherapy response in gastric cancer using digital pathology.
| Title: | Translational deep learning models for risk stratification to predict prognosis and immunotherapy response in gastric cancer using digital pathology. |
|---|---|
| Authors: | Nguyen MH; International Ph.D. Program in Cell Therapy and Regenerative Medicine, College of Medicine, Taipei Medical University, Taipei, 110, Taiwan.; Department of Pathology and Forensic Medicine, 103 Military Hospital, Hanoi, Vietnam.; AIBioMed Research Group, Taipei Medical University, Taipei, 110, Taiwan.; Do-Huu HH; University of Science, VNU-HCM, Ho Chi Minh City, Vietnam.; Vietnam National University, Ho Chi Minh City, Vietnam.; Nguyen PT; University of Science, VNU-HCM, Ho Chi Minh City, Vietnam.; Tran ND; Department of Pathology and Forensic Medicine, 103 Military Hospital, Hanoi, Vietnam.; Linh NT; Department of Pathology and Forensic Medicine, 103 Military Hospital, Hanoi, Vietnam.; Le H; Department of Computer Science, University of North Carolina at Charlotte, Charlotte, NC, 28223, USA.; Le NQK; AIBioMed Research Group, Taipei Medical University, Taipei, 110, Taiwan. khanhlee@tmu.edu.tw.; In-Service Master Program in Artificial Intelligence in Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan. khanhlee@tmu.edu.tw.; Translational Imaging Research Center, Taipei Medical University Hospital, Taipei, 110, Taiwan. khanhlee@tmu.edu.tw. |
| Source: | Journal of translational medicine [J Transl Med] 2025 Dec 24; Vol. 23 (1), pp. 1419. Date of Electronic Publication: 2025 Dec 24. |
| Publication Type: | Journal Article |
| Language: | English |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876 (Electronic) Linking ISSN: 14795876 NLM ISO Abbreviation: J Transl Med Subsets: MEDLINE; In Process |
| Imprint Name(s): | Original Publication: [London] : BioMed Central, 2003- |
| Competing Interests: | Declarations. Consent for publication: Written informed consent was obtained from all participants, and all procedures were conducted in compliance with applicable guidelines and regulations. Conflict of interest: The authors declare no conflicts of interest. |
| References: | Biochim Biophys Acta Rev Cancer. 2025 Apr;1880(2):189277. (PMID: 39938663); Conf Comput Vis Pattern Recognit Workshops. 2021 Jun;2021:14318-14328. (PMID: 35047230); Sci Rep. 2021 Nov 22;11(1):22636. (PMID: 34811485); World J Gastroenterol. 2022 Mar 28;28(12):1187-1203. (PMID: 35431510); MedComm (2020). 2023 Jan 23;4(1):e203. (PMID: 36703877); Eur J Cancer. 2018 Jun;96:115-124. (PMID: 29729562); J Pathol Clin Res. 2024 Nov;10(6):e70004. (PMID: 39358807); Nat Biomed Eng. 2021 Jun;5(6):555-570. (PMID: 33649564); Cancers (Basel). 2023 Jan 25;15(3):. (PMID: 36765710); Onco Targets Ther. 2018 Nov 21;11:8239-8250. (PMID: 30538493); J Hematol Oncol. 2024 Aug 9;17(1):65. (PMID: 39123202); J Transl Med. 2024 May 8;22(1):438. (PMID: 38720336); Signal Transduct Target Ther. 2022 Sep 19;7(1):331. (PMID: 36123348); Mod Pathol. 2023 Aug;36(8):100208. (PMID: 37149222); World J Gastroenterol. 2024 Feb 28;30(8):779-793. (PMID: 38516237); Ann Med. 2024 Dec;56(1):2426758. (PMID: 39527470); Semin Cancer Biol. 2023 Dec;97:104-123. (PMID: 38029865); Medicine (Baltimore). 2022 Oct 7;101(40):e30927. (PMID: 36221394); Sci Data. 2025 Jul 30;12(1):1326. (PMID: 40739145); J Digit Imaging. 2020 Aug;33(4):1034-1040. (PMID: 32468487); EBioMedicine. 2021 Nov;73:103631. (PMID: 34678610); Cancer Res Commun. 2024 Jan 11;4(1):92-102. (PMID: 38126740); Front Oncol. 2022 Sep 23;12:961637. (PMID: 36212414); Trends Cancer. 2020 Jul;6(7):580-592. (PMID: 32610068); Front Immunol. 2022 Apr 29;13:890922. (PMID: 35572498); NPJ Breast Cancer. 2023 Aug 30;9(1):71. (PMID: 37648694); Curr Issues Mol Biol. 2025 Jul 16;47(7):. (PMID: 40729021); Drug Resist Updat. 2020 Dec;53:100718. (PMID: 32736034); J Gastrointest Surg. 2024 Feb;28(2):151-157. (PMID: 38445936); Front Oncol. 2022 Nov 24;12:934249. (PMID: 36505771); Cancer Med. 2024 Aug;13(15):e7365. (PMID: 39096090); Am J Pathol. 2023 Oct;193(10):1517-1527. (PMID: 37356573); Cancers (Basel). 2024 Apr 15;16(8):. (PMID: 38672588); JAMA Oncol. 2018 May 10;4(5):e180013. (PMID: 29543932); Lancet. 2018 Jul 14;392(10142):123-133. (PMID: 29880231) |
| Contributed Indexing: | Keywords: Deep learning; Gastric cancer; Immunotherapeutic response; Prognoses; Whole-slide image |
| Entry Date(s): | Date Created: 20251225 Latest Revision: 20251228 |
| Update Code: | 20260130 |
| PubMed Central ID: | PMC12729749 |
| DOI: | 10.1186/s12967-025-07416-z |
| PMID: | 41444960 |
| Database: | MEDLINE |
Journal Article